BRIEF-EMA To Hold Exceptional Meeting On Dec. 21 To Assess…

Dec 15 (Reuters) — European Medicines Agency:

* EMA — UPDATE ON ASSESSMENT OF BIONTECH AND PFIZER BNT162B2 VACCINE MARKETING AUTHORISATION APPLICATION

* EMA — FOLLOWING RECEIPT OF ADDITIONAL DATA REQUESTED BY CHMP FROM PFIZER, EXCEPTIONAL MEETING OF CHMP SCHEDULED FOR panel all sosmed 21 DEC TO CONCLUDE IF POSSIBLE

* EMA — MEETING PLANNED FOR 29 DECEMBER WILL BE MAINTAINED IF NEEDED

* EMA — CHMP WILL CONCLUDE ITS ASSESSMENT OF BIONTECH AND PFIZER VACCINE AT THE EARLIEST POSSIBLE TIMEPOINT Source text: website Further company coverage: